[PDF][PDF] Notch activation as a driver of osteogenic sarcoma

J Tao, MM Jiang, L Jiang, JS Salvo, HC Zeng… - Cancer cell, 2014 - cell.com
J Tao, MM Jiang, L Jiang, JS Salvo, HC Zeng, B Dawson, TK Bertin, PH Rao, R Chen
Cancer cell, 2014cell.com
Osteogenic sarcoma (OS) is a deadly skeletal malignancy whose cause is unknown. We
report here a mouse model of OS based on conditional expression of the intracellular
domain of Notch1 (NICD). Expression of the NICD in immature osteoblasts was sufficient to
drive the formation of bone tumors, including OS, with complete penetrance. These tumors
display features of human OS; namely, histopathology, cytogenetic complexity, and
metastatic potential. We show that Notch activation combined with loss of p53 synergistically …
Summary
Osteogenic sarcoma (OS) is a deadly skeletal malignancy whose cause is unknown. We report here a mouse model of OS based on conditional expression of the intracellular domain of Notch1 (NICD). Expression of the NICD in immature osteoblasts was sufficient to drive the formation of bone tumors, including OS, with complete penetrance. These tumors display features of human OS; namely, histopathology, cytogenetic complexity, and metastatic potential. We show that Notch activation combined with loss of p53 synergistically accelerates OS development in mice, although p53-driven OS is not Rbpj dependent, which demonstrates a dual dominance of the Notch oncogene and p53 mutation in the development of OS. Using this model, we also reveal the osteoblasts as the potential sources of OS.
cell.com